RAPPOSELLI, ILARIO GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 1.542
NA - Nord America 841
EU - Europa 550
SA - Sud America 64
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 56
OC - Oceania 1
Totale 3.115
Nazione #
US - Stati Uniti d'America 810
CN - Cina 387
SG - Singapore 376
VN - Vietnam 370
IT - Italia 217
HK - Hong Kong 107
KR - Corea 88
BD - Bangladesh 57
DE - Germania 52
IN - India 51
BR - Brasile 47
SE - Svezia 47
FR - Francia 36
FI - Finlandia 33
JP - Giappone 26
NL - Olanda 26
IE - Irlanda 22
CI - Costa d'Avorio 21
GB - Regno Unito 20
UA - Ucraina 17
CH - Svizzera 16
RU - Federazione Russa 16
IQ - Iraq 13
PH - Filippine 13
SC - Seychelles 12
AT - Austria 11
CA - Canada 10
ID - Indonesia 10
PK - Pakistan 8
TH - Thailandia 8
AR - Argentina 7
BG - Bulgaria 7
JM - Giamaica 7
JO - Giordania 7
MX - Messico 7
ZA - Sudafrica 7
PL - Polonia 6
TR - Turchia 6
TW - Taiwan 5
GR - Grecia 4
NG - Nigeria 4
DZ - Algeria 3
EC - Ecuador 3
ES - Italia 3
KE - Kenya 3
PT - Portogallo 3
SA - Arabia Saudita 3
TG - Togo 3
UZ - Uzbekistan 3
BE - Belgio 2
BY - Bielorussia 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HR - Croazia 2
LB - Libano 2
MA - Marocco 2
RO - Romania 2
AU - Australia 1
BO - Bolivia 1
HN - Honduras 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
MQ - Martinica 1
NO - Norvegia 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
VE - Venezuela 1
Totale 3.054
Città #
Singapore 281
Hefei 183
Ashburn 106
Hanoi 96
Hong Kong 94
Ho Chi Minh City 92
Seoul 85
San Jose 79
Dallas 48
Santa Clara 45
Council Bluffs 40
Bologna 35
New York 34
Beijing 32
Helsinki 27
Los Angeles 27
Boardman 26
Chandler 22
Dublin 22
Abidjan 21
Tokyo 20
Bengaluru 18
Lauterbourg 18
Fairfield 17
Bern 16
Da Nang 16
Milan 16
Rome 15
Kyiv 13
Modena 12
Princeton 12
Turin 12
Phoenix 11
Baghdad 9
Frankfurt am Main 9
Haiphong 9
Jakarta 9
São Paulo 9
Amsterdam 8
Chicago 8
Nuremberg 8
Redondo Beach 8
Munich 7
Sofia 7
Southend 7
Vienna 7
Amman 6
Buffalo 6
Charlotte 6
Falkenstein 6
Florence 6
Houston 6
Johannesburg 6
Lappeenranta 6
Perugia 6
Shanghai 6
Tongling 6
Tân Tiến 6
Abbadia San Salvatore 5
Bến Tre 5
Denver 5
Düsseldorf 5
Forlì 5
Messina 5
Ninh Bình 5
Salt Lake City 5
San Diego 5
Seattle 5
Warsaw 5
Berlin 4
Biên Hòa 4
Brooklyn 4
Cambridge 4
Cao Lanh 4
Guangzhou 4
Hải Dương 4
Kingston 4
Quảng Ngãi 4
Rimini 4
Woodbridge 4
Belo Horizonte 3
Boston 3
Des Moines 3
Guayaquil 3
Hyderabad 3
Jacksonville 3
Las Vegas 3
Lomé 3
London 3
New Orleans 3
Nha Trang 3
Orem 3
Ottawa 3
Parma 3
San Francisco 3
Stockholm 3
Tashkent 3
Tiền Hải 3
Trento 3
Vũng Tàu 3
Totale 1.927
Nome #
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value 227
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 227
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 220
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 201
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape: Bertinoro Workshop, November 2022 199
Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: A prospective observational protocol 197
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 181
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial 170
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 165
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 160
Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma. 156
Multimodal treatment with gemox plus helical tomotherapy in unresectable locally advanced pancreatic cancer: A pooled analysis of two phase 2 studies 152
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 150
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab 141
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 123
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma 111
Equivalent efficacy but different safety profiles of gemcitabine plus nab-paclitaxel and folfirinox in metastatic pancreatic cancer 95
Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers 80
A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study 62
Impact of RAS, BRAF mutations and microsatellite status in peritoneal metastases from colorectal cancer treated with cytoreduction + HIPEC: scoping review 52
Cholecystostomy: how to get a safe way to perform a percutaneous biopsy of the pancreatic head 46
Totale 3.115
Categoria #
all - tutte 8.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202288 0 0 1 1 3 1 1 22 10 3 34 12
2022/2023173 10 16 8 6 8 8 4 14 35 12 21 31
2023/2024111 5 11 9 17 9 20 3 11 7 6 3 10
2024/2025548 22 37 37 38 47 27 39 29 13 47 59 153
2025/20261.955 172 234 151 134 122 69 363 64 337 133 93 83
2026/2027218 80 57 81 0 0 0 0 0 0 0 0 0
Totale 3.115